In terms of its link to cancer progression, Tudor-SN has been shown to promote resistance to apoptosis and to be induced by NF-κB, which as mentioned above, was increased in the CD-induced tissues through potentially decreased miR-146a and 146b expression (Figure 5) [45, 49]. The gene discussed is NFKB1; the disease is cancer.